fibrinogen (human) (RiaSTAP) Report issue

Biological Orphan Drug FDA Approved FDA
AACT ChEMBL DrugBank PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.7000 - $0.9500
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

beriplast p | coagulation factor i | factor i (fibrinogen) | factor i human | fibrinogen | fibrinogen concentrate human | fibrinogen concentrate (human) | fibrinogen human | fibrinogen (human) | fibrinogen, human | fibrinogen human plasma-derived | fibrogen | human fibrinogen | riastap

Organizations (87)

Research & Development (84)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (48)

Approved Indications (1)


 

Afibrinogenemia (approved 2009)

Experimental Indications - Clinical Trial Phases 1-4 (48)


 

Afibrinogenemia (Phase 4)

Aneurysm (Phase 4)

Aortic Aneurysm (Phase 2)

Aortic Diseases (Phase 2)

Bleeding Time (Phase 4)

Blood Coagulation (Phase 4)

Blood Coagulation Disorders (Phase 4)

Blood Loss, Surgical (Phase 3)

Blood Platelet Disorders (Phase 2)

Brain Injuries, Traumatic (Phase 1/Phase 2)

Bronchiectasis (Phase 2/Phase 3)

Cardiac Surgical Procedures (Phase 2)

Coronary Artery Disease (Phase 2)

Deficiency Diseases (Phase 4)

Disseminated Intravascular Coagulation (Phase 4)

Fibrin (Phase 4)

Fibrinogen (Phase 4)

General Surgery (Phase 4)

Heart Defects, Congenital (Phase 4)

Heart Diseases (Phase 3)

Heart Valve Diseases (Phase 2)

Hematologic Diseases (Phase 2)

Hemorrhage (Phase 4)

Hemostasis (Phase 4)

Intracranial Hemorrhages (Phase 3)

Intraoperative Complications (Phase 3)

Ischemic Stroke (Phase 3)

Liver Diseases (Phase 3)

Liver Transplantation (Phase 4)

Lung Diseases (Phase 3)

Multiple Trauma (Phase 1/Phase 2)

Pancreatic Neoplasms (Phase 4)

Pediatrics (Phase 4)

Postoperative Hemorrhage (Phase 3)

Postpartum Hemorrhage (Phase 4)

Pterygium (Phase 3)

Scoliosis (Phase 3)

Sepsis (Phase 3)

Shock (Phase 3)

Shock, Hemorrhagic (Phase 3)

Shock, Septic (Phase 3)

Spinal Injuries (Phase 4)

Thrombosis (Phase 4)

Tissue Adhesions (Phase 2)

Transfusion Reaction (Phase 2)

Transfusion-Related Acute Lung Injury (Phase 2)

Traumatology (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 73
  • # of Trial Organizations: 84

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue